Initial Experience With Commercial Transcatheter Mitral Valve Repair in the United States.

[1]  D. Capodanno,et al.  Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry. , 2014, European heart journal cardiovascular Imaging.

[2]  S. Blankenberg,et al.  Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. , 2014, Journal of the American College of Cardiology.

[3]  M. Post,et al.  Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patients. , 2014, JACC. Cardiovascular interventions.

[4]  M. Mack,et al.  Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. , 2014, Journal of the American College of Cardiology.

[5]  M. Mack,et al.  Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. , 2014, Journal of the American College of Cardiology.

[6]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[7]  Thoralf M Sundt,et al.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[8]  D. Hagler,et al.  The learning curve in percutaneous repair of paravalvular prosthetic regurgitation: an analysis of 200 cases. , 2014, JACC. Cardiovascular interventions.

[9]  N. Smedira,et al.  Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. , 2014, Journal of the American College of Cardiology.

[10]  Sean M. O'Brien,et al.  Outcomes following transcatheter aortic valve replacement in the United States. , 2013, JAMA.

[11]  J. Hausleiter,et al.  Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. , 2013, Journal of the American College of Cardiology.

[12]  Danica Marinac-Dabic,et al.  The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. , 2013, Journal of the American College of Cardiology.

[13]  H. Katus,et al.  One year clinical efficacy and reverse cardiac remodelling in patients with severe mitral regurgitation and reduced ejection fraction after MitraClip© implantation , 2013, European journal of heart failure.

[14]  Martin Misfeld,et al.  Learning Minimally Invasive Mitral Valve Surgery: A Cumulative Sum Sequential Probability Analysis of 3895 Operations From a Single High-Volume Center , 2013, Circulation.

[15]  E. Foster,et al.  4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. , 2013, Journal of the American College of Cardiology.

[16]  P. Boekstegers,et al.  Acute outcomes after MitraClip therapy in highly aged patients: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) Registry. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[17]  D. Capodanno,et al.  One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry). , 2013, The American journal of cardiology.

[18]  G. Rioufol,et al.  Initial French experience of percutaneous mitral valve repair with the MitraClip: a multicentre national registry. , 2013, Archives of cardiovascular diseases.

[19]  K. Rufibach,et al.  Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry , 2013, Heart.

[20]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, The Journal of thoracic and cardiovascular surgery.

[21]  O. Alfieri,et al.  Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[22]  M. Mack,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.

[23]  C. Nienaber,et al.  In-hospital outcome of patients with severe mitral valve regurgitation classified as inoperable and treated with the MitraClip® device. , 2012, Journal of interventional cardiology.

[24]  Pascal Vranckx,et al.  Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. , 2012, Journal of the American College of Cardiology.

[25]  Pascal Vranckx,et al.  Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. , 2011, Journal of the American College of Cardiology.

[26]  P. Serruys,et al.  Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium , 2010, European heart journal.

[27]  J. Gorman,et al.  Percutaneous repair or surgery for mitral regurgitation. , 2011, The New England journal of medicine.

[28]  H. Reichenspurner,et al.  Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. , 2010, European heart journal.

[29]  M. Enriquez-Sarano,et al.  Outcomes in mitral regurgitation due to flail leaflets a multicenter European study. , 2008, JACC. Cardiovascular imaging.

[30]  Philippe Ravaud,et al.  What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? , 2007, European heart journal.

[31]  E. Foster,et al.  Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. , 2005, Journal of the American College of Cardiology.

[32]  M. Enriquez-Sarano,et al.  Quantitative determinants of the outcome of asymptomatic mitral regurgitation. , 2005, The New England journal of medicine.

[33]  R A Levine,et al.  Prevalence and clinical outcome of mitral-valve prolapse. , 1999, The New England journal of medicine.

[34]  M. Enriquez-Sarano,et al.  Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. , 1999, Circulation.

[35]  J B Seward,et al.  Clinical outcome of mitral regurgitation due to flail leaflet. , 1996, The New England journal of medicine.

[36]  M. Enriquez-Sarano,et al.  Echocardiographic Prediction of Survival After Surgical Correction of Organic Mitral Regurgitation , 1994, Circulation.